- Home
- INM vs NDRA Comparison
INM vs NDRA Comparison
Compare INM & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- NDRA
- Stock Information
- Founded
- INM 1981
- NDRA 2007
- Country
- INM Canada
- NDRA United States
- Employees
- INM N/A
- NDRA N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INM Health Care
- NDRA Health Care
- Exchange
- INM Nasdaq
- NDRA Nasdaq
- Market Cap
- INM 3.4M
- NDRA 3.6M
- IPO Year
- INM N/A
- NDRA 2017
- Fundamental
- Price
- INM $4.95
- NDRA $6.01
- Analyst Decision
- INM
- NDRA Strong Buy
- Analyst Count
- INM 0
- NDRA 1
- Target Price
- INM N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- INM 26.6K
- NDRA 36.2K
- Earning Date
- INM 02-11-2025
- NDRA 11-15-2024
- Dividend Yield
- INM N/A
- NDRA N/A
- EPS Growth
- INM N/A
- NDRA N/A
- EPS
- INM N/A
- NDRA N/A
- Revenue
- INM $4,960,506.00
- NDRA N/A
- Revenue This Year
- INM N/A
- NDRA N/A
- Revenue Next Year
- INM N/A
- NDRA N/A
- P/E Ratio
- INM N/A
- NDRA N/A
- Revenue Growth
- INM 5.17
- NDRA N/A
- 52 Week Low
- INM $2.42
- NDRA $4.01
- 52 Week High
- INM $15.70
- NDRA $2,240.00
- Technical
- Relative Strength Index (RSI)
- INM 55.90
- NDRA 51.58
- Support Level
- INM $4.07
- NDRA $5.60
- Resistance Level
- INM $5.41
- NDRA $6.29
- Average True Range (ATR)
- INM 0.39
- NDRA 0.60
- MACD
- INM 0.01
- NDRA 0.02
- Stochastic Oscillator
- INM 67.83
- NDRA 27.29
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.